Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad

por Okita, Riki, Shimizu, Katsuhiko, Nojima, Yuji, Saisho, Shinsuke, Nakata, Masao
Publicado 2021

Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer

por Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Nojima, Yuji, Nakata, Masao
Publicado 2015

Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report

por Maeda, Ai, Nakata, Masao, Shimizu, Katsuhiko, Yukawa, Takuro, Saisho, Shinsuke, Okita, Riki
Publicado 2016

Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings

por Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Nojima, Yuji, Nakata, Masao
Publicado 2016

Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma

por Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Nojima, Yuji, Nakata, Masao
Publicado 2017

Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer

por Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Nojima, Yuji, Nakata, Masao
Publicado 2019

Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer

por Okita, Riki, Maeda, Ai, Shimizu, Katsuhiko, Nojima, Yuji, Saisho, Shinsuke, Nakata, Masao
Publicado 2019

Membrane-bound estrogen receptor-α expression and epidermal growth factor receptor mutation are associated with a poor prognosis in lung adenocarcinoma patients

por Shimizu, Katsuhiko, Hirami, Yuji, Saisho, Shinsuke, Yukawa, Takuro, Maeda, Ai, Yasuda, Koichiro, Nakata, Masao
Publicado 2012

Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma...

por Shimizu, Katsuhiko, Maeda, Ai, Yukawa, Takuro, Nojima, Yuji, Saisho, Shinsuke, Okita, Riki, Nakata, Masao
Publicado 2014

Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy

por Shimizu, Katsuhiko, Yukawa, Takuro, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Nojima, Yuji, Nakata, Masao
Publicado 2015

Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer

por Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Yukawa, Takuro, Maeda, Ai, Nojima, Yuji, Nakata, Masao
Publicado 2015

Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer

por Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Yukawa, Takuro, Maeda, Ai, Nojima, Yuji, Nakata, Masao
Publicado 2015

Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells

por OKITA, RIKI, SHIMIZU, KATSUHIKO, NOJIMA, YUJI, YUKAWA, TAKURO, MAEDA, AI, SAISHO, SHINSUKE, NAKATA, MASAO
Publicado 2015

Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis

por MAEDA, AI, NAKATA, MASAO, YASUDA, KOICHIRO, YUKAWA, TAKURO, SAISHO, SHINSUKE, OKITA, RIKI, HIRAMI, YUJI, SHIMIZU, KATSUHIKO
Publicado 2012

A case report of intrapulmonary schwannoma

por Yukawa, Takuro, Shimizu, Katsuhiko, Hirami, Yuji, Okita, Riki, Saisho, Shinsuke, Maeda, Ai, Yasuda, Koichiro, Nakata, Masao
Publicado 2013

Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma

por Yamagishi, Tomoko, Shimizu, Katsuhiko, Ochi, Nobuaki, Yamane, Hiromichi, Irei, Isao, Sadahira, Yoshito, Takigawa, Nagio, Oka, Mikio, Nakata, Masao
Publicado 2014

Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in...

por Okita, Riki, Wolf, Diana, Yasuda, Koichiro, Maeda, Ai, Yukawa, Takuro, Saisho, Shinsuke, Shimizu, Katsuhiko, Yamaguchi, Yoshiyuki, Oka, Mikio, Nakayama, Eiichi, Lundqvist, Andreas, Kiessling, Rolf, Seliger, Barbara, Nakata, Masao
Publicado 2015

Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non–small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701

por Soh, Junichi, Okumura, Norihito, Nakata, Masao, Nakamura, Hiroshige, Fukuda, Minoru, Kataoka, Masafumi, Kajiwara, Shinsuke, Sano, Yoshifumi, Aoe, Motoi, Kataoka, Kazuhiko, Hotta, Katsuyuki, Matsuo, Keitaro, Toyooka, Shinichi, Date, Hiroshi
Publicado 2016

Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setou...

por Okumura, Norihito, Soh, Junichi, Suzuki, Hiroyuki, Nakata, Masao, Fujiwara, Toshiya, Nakamura, Hiroshige, Sonobe, Makoto, Fujinaga, Takuji, Kataoka, Kazuhiko, Gemba, Kenichi, Kataoka, Masafumi, Hotta, Katsuyuki, Yoshioka, Hiroshige, Matsuo, Keitaro, Sakamoto, Junichi, Date, Hiroshi, Toyooka, Shinichi
Publicado 2021

Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)—IIIA...

por Yamamoto, Hiromasa, Soh, Junichi, Okumura, Norihito, Suzuki, Hiroyuki, Nakata, Masao, Fujiwara, Toshiya, Gemba, Kenichi, Sano, Isao, Fujinaga, Takuji, Kataoka, Masafumi, Terazaki, Yasuhiro, Fujimoto, Nobukazu, Kataoka, Kazuhiko, Kosaka, Shinji, Yamashita, Motohiro, Inokawa, Hidetoshi, Inoue, Masaaki, Nakamura, Hiroshige, Yamashita, Yoshinori, Hotta, Katsuyuki, Yoshioka, Hiroshige, Morita, Satoshi, Matsuo, Keitaro, Sakamoto, Junichi, Date, Hiroshi, Toyooka, Shinichi
Publicado 2023